Metformin in Ovarian Cancer

Metformin after its discovery has found many wonders in many varied uses, poly cystic ovarian disease being already established one. It is now standard therapy in such condition. Many enchanting pathways are depicted leading to its many efficacies. In last decade its use in ovarian and other cancers is proposed. Before another such use is proved we can see the subject had grown bigger; hence a review seems to be worthwhile

Full article: https://www.hilarispublisher.com/open-access/metformin-in-ovarian-cancer-JOTR-1000102.pdf

Journal of Oncology Translational Research with ISSN number: 2476-2261 is seeking to publish articles that includes a wide range of topics in this field and creates a platform for the authors to make their contribution towards the journal. The journal covers all aspects of modern research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients and creates a platform for the authors to contribute towards the journal. The authors may forward the manuscript as an email attachment whereby the editorial office takes care of the further processing.

To submit manuscript online please click here: https://www.scholarscentral.org/submissions/oncology translational-research.html To send as attachment, email to: oncologytransres@oncologyinsights.org

Media contact,
Jessica Rose
Journal of Oncology Translational Research
Email: oncologytransres@medicalresjournals.com